We are eying fruitation of breakthrough findings to make innovations enjoyable. We are “VRL (Venus Remedies Limited)”, a research driven Indian Pharmaceutical company with global footprints.
Scientific ingenuity is the building block of research at Venus. We believe in catering the unmet medical needs through translational research. Since 2004, Venus has been an active participant in infectious disease research in India and has an extensive portfolio of patented research products targeting Antimicrobial Resistance.
It is essential to us that our research is timed appropriately to enable us to make healthcare interventions in time. The outcry for AMR was lesser known when we identified this as an upcoming global health problem and set out on a mission to save the antibiotics. Our incessant efforts and overwhelming desire to combat resistance in antibiotics led us to developing the concept of an Antibiotic Adjuvant Entity that has the potential to treat some of the most threating and fatal pathogens.
